Reuters logo
BRIEF-Jerusalem Pharmaceuticals FY profit after tax rises
February 15, 2017 / 1:22 PM / 8 months ago

BRIEF-Jerusalem Pharmaceuticals FY profit after tax rises

Feb 15 (Reuters) - Jerusalem Pharmaceuticals Co:

* FY net profit after tax $3.2 million versus $2.2 million year ago

* FY sales $28.6 million versus $28.7 million year ago Source: (bit.ly/2kScN9A) Further company coverage: )

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below